Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)
Artivion (AORT) posted Liabilities and Shareholders Equity of $883.2 million for Q1 2026, little changed on a QoQ basis from $884.8 million in Q4 2025, and up 11.63% year-over-year from $791.2 million in Q1 2025.
Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Artivion's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $883.2 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 9.17% YoY) and the FY2025 annual result came in at $884.8 million, up 12.13% from the prior year.
- Liabilities and Shareholders Equity was $883.2 million for Q1 2026 at Artivion, roughly flat from $884.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $884.8 million in Q4 2025 and bottomed at $742.7 million in Q3 2022.
- A 5-year average of $798.5 million and a median of $789.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 9.27% — and 2025, when it rose 12.13%.
- Artivion's Liabilities and Shareholders Equity stood at $762.8 million in 2022, then advanced by 3.88% to $792.4 million in 2023, then declined by 0.42% to $789.1 million in 2024, then advanced by 12.13% to $884.8 million in 2025, then slipped by 0.19% to $883.2 million in 2026.
- Business Quant data shows AORT's Liabilities and Shareholders Equity at $883.2 million in Q1 2026, $884.8 million in Q4 2025, and $857.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 883.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 883.16 Mn |
| Dec 31, 2025 | 884.80 Mn |
| Sep 30, 2025 | 857.66 Mn |
| Jun 30, 2025 | 838.39 Mn |
| Mar 31, 2025 | 791.16 Mn |
| Dec 31, 2024 | 789.10 Mn |
| Sep 30, 2024 | 803.14 Mn |
| Jun 30, 2024 | 789.54 Mn |
| Mar 31, 2024 | 784.01 Mn |
| Dec 31, 2023 | 792.40 Mn |
| Sep 30, 2023 | 774.79 Mn |
| Jun 30, 2023 | 777.86 Mn |
| Mar 31, 2023 | 757.07 Mn |
| Dec 31, 2022 | 762.80 Mn |
| Sep 30, 2022 | 742.73 Mn |
| Jun 30, 2022 | 764.86 Mn |
| Mar 31, 2022 | 781.86 Mn |
| Dec 31, 2021 | 793.05 Mn |
| Sep 30, 2021 | 818.65 Mn |
| Jun 30, 2021 | 810.50 Mn |